piperazin-1-yl(tetrahydrofuran-2-yl)methanone; 1-?Piperazinyl(tetrahyd?ro-?2-?furanyl)?-methanone; 1-?[(tetrahydro-?2-?furanyl)?carbonyl]?-piperazine; (Piperazin-?1-?yl)?(tetrahydrofuran-?2-?yl)?methanone; 1-?(Tetrahydro-?2-?furoyl)?piperazine; 1-?(Tetrahydrofuran-?2-?carbonyl)?piperazine; 1-?(Tetrahydrofuran-?2-?ylcarbonyl)?piperazine; 1-?[(2,?3,?4,?5-?Tetrahydrofuran-?2-?yl)?carbonyl]?piperazine; 4-?[(Tetrahydrofuran-?2-?yl)?carbonyl]?piperazine; N-?(Tetrahydro-?2-?furoyl)?piperazine; Terazosin EP Impurity N
Terazosin EP Impurity N is a fully characterized chemical compound used as a reference standard of API Terazosin. The standard offered is compliant with regulatory guidelines. Terazosin EP Impurity N is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 63074-07-7
